Tolerance of pool therapy by ankylosing spondylitis patients with low vital capacities
Harrison, R.A.
PhysioTherapy 67(10): 296
1981
ISSN/ISBN: 0031-9406 PMID: 7330100 Document Number: 171644
Document emailed within 1 workday
Related Documents
Grazio, S.; Grubisić, F.; Nemcić, T.; Matijević, V.; Skala, H. 2009: The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis Reumatizam 56(2): 63-76Ozdem Yr, O.; Inanici, F.; Hasçelik, Z. 2011: Reduced vital capacity leads to exercise intolerance in patients with ankylosing spondylitis European Journal of Physical and Rehabilitation Medicine 47(3): 391-397
Seçkin, U.; Bölükbasi, N.; Gürsel, G.; Eröz, S.; Sepici, V.; Ekim, N. 2000: Relationship between pulmonary function and exercise tolerance in patients with ankylosing spondylitis Clinical and Experimental Rheumatology 18(4): 503-506
Heldmann, F.; Brandt, J.; van der Horst-Bruinsma, I.E.; Landewe, R.; Sieper, J.; Burmester, G.R.; van den Bosch, F.; de Vlam, K.; Geusens, P.; Gaston, H.; Schewe, S.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M.; Listing, J.; Braun, J. 2011: The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab Clinical and Experimental Rheumatology 29(4): 672-680
Sieper, J.; Braun, J. 2002: New treatment strategies in ankylosing spondylitis: Proceedings of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 January 2002 Annals of the Rheumatic Diseases 61 Suppl. 3: Iii1-Iii2
Genre, F.; López-Mejías, R.; Miranda-Filloy, J.A.; Carnero-López, B.; Gómez-Acebo, I.és.; Blanco, R.; Ochoa, R.; Rueda, J.; González-Juanatey, C.; Llorca, J.; González-Gay, M.A. 2013: Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy Clinical and Experimental Rheumatology 31(5): 749-755
Villa Alcázar, L.F.; de Buergo, M.; Rico Lenza, H.; Montull Fruitós, E. 1996: Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis Journal of Rheumatology 23(7): 1194-1199
Kim, T.-J.; Shin, J.-H.; Sung, I.-H.; Lee, S.; Song, Y.; Kim, T.-H. 2016: Comparison on radiographic progression for 5 years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy Registry (OSKAR) data Clinical and Experimental Rheumatology 34(4): 668-672
Calin, A.; Garrett, S.; Whitelock, H.; Kennedy, L.G.; O'Hea, J.; Mallorie, P.; Jenkinson, T. 1994: A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index Journal of Rheumatology 21(12): 2281-2285
Appel, H.; Scheer, R.; Haibel, H.; Wu, P.; Spiller, I.; Brandt, H.; Song, I-Ho.; Rudwaleit, M.; Thiel, A.; Sieper, J. 2007: In vitro observations of T cell responsiveness to recall antigens during tumor necrosis factor-alpha-blocking therapy in patients with ankylosing spondylitis Journal of Rheumatology 34(11): 2264-2270
Zochling, J.; Sieper, J.; van der Heijde, Désirée.; Braun, Jürgen.; Weber, U.; Rudwaleit, M.; Leirisalo-Repo, M.; Collantes-Estévez, E.; van der Horst-Bruinsma, I.; Géher, P.; Kvien, T.; deVlam, K.; l Ostergaard, M.; Maksymowych, W. 2008: Development of a core set of domains for data collection in cohorts of patients with ankylosing spondylitis receiving anti-tumor necrosis factor-alpha therapy Journal of Rheumatology 35(6): 1079-1082
Bakker, C.; Hidding, A.; van der Linden, S.; van Doorslaer, E. 1994: Cost effectiveness of group physical therapy compared to individualized therapy for ankylosing spondylitis. A randomized controlled trial Journal of Rheumatology 21(2): 264-268
Koch, W. 1978: Indications and results of radium 224 (thorium X) therapy of ankylosing spondylitis Zeitschrift für Orthopadie und ihre Grenzgebiete 116(4): 608-616
Samborski, W.; Sobieska, M.; Mackiewicz, T.; Stratz, T.; Mennet, M.; Müller, W. 1992: Can thermal therapy of ankylosing spondylitis induce an activation of the disease? Zeitschrift für Rheumatologie 51(3): 127-131
Sanli, H.; Ataman, S.; Akay, B.ü N.; Yilmaz, A.; Yildizlar, D.; Gürgey, E. 2007: Mycosis fungoides in a patient with ankylosing spondylitis during infliximab therapy Journal of Drugs in Dermatology: Jdd 6(8): 834-836
Mercado, U. 1994: The use of methylprednisolone pulse therapy in a severe case of HLA-B27 negative ankylosing spondylitis Journal of Rheumatology 21(8): 1582-1583
Baldini, N.; Bungaro, P.; Toni, A. 1984: Hip prosthesis in patients with ankylosing spondylitis La Chirurgia Degli Organi di Movimento 69(4): 323-328
Menkes, C.J.; Kahan, A.; Feldmann, J.L.; Vinh, T. 1983: Destructive cervical spondylitis. An unusual initial manifestation of ankylosing spondylitis Presse Medicale 12(4): 227-229
Liu, H.C. 1984: Immunological aberrations in ankylosing spondylitis patients Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 17(1): 19-24
Sánchez Bursón, J.M.; Martínez Manzanares, C.; Montero Iruzubieta, J.; González de la Vera, J.; Rodríguez Bando, J.; Ortega Calvo, M.; Romero Velasco, E. 1987: T-4, T-8 and NK lymphocyte subpopulations in patients with ankylosing spondylitis Revista Clinica Espanola 180(2): 74-76